Back to results
US 11,685,761 B2Granted
Cyclic di-nucleotide compounds as sting agonists
AssigneeMerck Sharp & Dohme Corp.
InventorsBrian M. Andresen, Frank Bennett, Wonsuk Chang, Matthew Lloyd Childers, Jared N. Cumming, Jongwon Lim, Min Lu, Benjamin Wesley Trotter, Wen-Lian Wu
Life of this patent
Estimating the term…
Abstract
A class of polycyclic compounds of general formula (I), wherein Base1, Base2, Y, Za, Xa, Xa1, Xb, Xb1, Xc, Xc1, Xd, Xd1, R1, R1a, R2, R2a, R3, R4, R4a, R5, R6, R6a, R7, R7a, R8, R8a, and R9 are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds.
Claims20
A compound of formula (I):
- or a pharmaceutically acceptable salt thereof, wherein
- Base1 and Base2 are each independently selected from the group consisting of
- wherein
- at least one of Base1 and Base2 is each independently selected from the group consisting of
- and
- Base1 and Base2 each may be independently substituted by 0-3 substituents R10, where each R10 is independently selected from the group consisting of F, Cl, I, Br, OH, SH, NH2, C1-3 alkyl, C3-6 cycloalkyl, O(C1-3 alkyl), O(C3-6 cycloalkyl), S(C1-3 alkyl), S(C3-6 cycloalkyl), NH(C1-3 alkyl), NH(C3-6 cycloalkyl), N(C1-3 alkyl)2, and N(C3-6 cycloalkyl)2;
- Y and Ya are each independently selected from the group consisting of —S—, —SO2—, —CH2—, and —CF2—;
- Xa and Xa1 are each independently selected from the group consisting of —O—, —S—, and —CH2—;
- Xb and Xb1 are each independently selected from the group consisting of —O—, —S—, and —CH2—;
- Xc and Xc1 are each independently selected from the group consisting of —SR9, —OR9, and —NR9R9,
- Xd and Xd1 are each independently selected from the group consisting of O and S;
- R1 and R1a are each independently selected from the group consisting of H, F, Cl, Br, I, OH, CN, N3, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl, where said R1 and R1a C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl are substituted by 0 to 3 substituents selected from the group consisting of F, Cl, Br, I, OH, CN, and N3;
- R2 and R2a are each independently selected from the group consisting of H, F, Cl, Br, I, OH, CN, N3, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl, where said R2 and R2a C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl are substituted by 0 to 3 substituents selected from the group consisting of F, Cl, Br, I, OH, CN, and N3;
- R3 is selected from the group consisting of H, F, Cl, Br, I, OH, CN, N3, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl, where said R3 C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl are substituted by 0 to 3 substituents selected from the group consisting of F, Cl, Br, I, OH, CN, and N3;
- R4 and R4a are each independently selected from the group consisting of H, F, Cl, Br, I, OH, CN, N3, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl, where said R4 and R4a C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl are substituted by 0 to 3 substituents selected from the group consisting of F, Cl, Br, I, OH, CN, and N3;
- R5 is selected from the group consisting of H, F, Cl, Br, I, OH, CN, N3, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl, where said R5 C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl are substituted by 0 to 3 substituents selected from the group consisting of F, Cl, Br, I, OH, CN, and N3;
- R6 and R6a are each independently selected from the group consisting of H, F, Cl, Br, I, OH, CN, N3, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl, where said R6 and R6′ C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl are substituted by 0 to 3 substituents selected from the group consisting of F, Cl, Br, I, OH, CN, and N3;
- R7 and R7a are each independently selected from the group consisting of H, F, Cl, Br, I, OH, CN, N3, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl, where said R7 and R7a C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl are substituted by 0 to 3 substituents selected from the group consisting of F, Cl, Br, I, OH, CN, and N3;
- R8 and R8a are each independently selected from the group consisting of H, F, Cl, Br, I, OH, CN, N3, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl, where said R8 and R8a C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, —O—C1-C6 alkyl, —O—C2-C6 alkenyl, and —O—C2-C6 alkynyl are substituted by 0 to 3 substituents selected from the group consisting of F, Cl, Br, I, OH, CN, and N3;
- each R9 is independently selected from the group consisting of H, C1-C20 alkyl,
- where each R9 C1-C20 alkyl is optionally substituted by 0 to 3 substituents independently selected from the group consisting of OH, —O—C1-C20 alkyl, —S—C(O)C1-C6 alkyl, and C(O)OC1-C6 alkyl;
- optionally R1a and R3 are connected to form C1-C6 alkylene, C2-C6 alkenylene, —O—C1-C6 alkylene, or —O—C2-C6 alkenylene, such that where R1a and R3 are connected to form —O—C1-C6 alkylene, or —O—C2-C6 alkenylene, said O is bound at the R3 position;
- optionally R2a and R3 are connected to form C1-C6 alkylene, C2-C6 alkenylene, —O—C1-C6 alkylene, or —O—C2-C6 alkenylene, such that where R2a and R3 are connected to form —O—C1-C6 alkylene, or —O—C2-C6 alkenylene, said O is bound at the R3 position;
- optionally R3 and R6′ are connected to form C1-C6 alkylene, C2-C6 alkenylene, —O—C1-C6 alkylene, or —O—C2-C6 alkenylene, such that where R3 and R6′ are connected to form —O—C1-C6 alkylene, or —O—C2-C6 alkenylene, said O is bound at the R3 position;
- optionally R4 and R5 are connected to form C1-C6 alkylene, C2-C6 alkenylene, —O—C1-C6 alkylene, or —O—C2-C6 alkenylene, such that where R4 and R5 are connected to form —O—C1-C6 alkylene, or —O—C2-C6 alkenylene, said O is bound at the R5 position;
- optionally R5 and R6 are connected to form —O—C1-C6 alkylene, —O—C2-C6 alkenylene, or —O—C2-C6 alkynylene, such that where R5 and R6 are connected to form C1-C6 alkylene, —O—C2-C6 alkenylene, or —O—C2-C6 alkynylene, said O is bound at the R5 position;
- optionally R7 and R8 are connected to form C1-C6 alkylene or C2-C6 alkenylene;
- and
- optionally R7a and R8a are connected to form C1-C6 alkylene or C2-C6 alkenylene.
26 more elements
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.